So what’s happening in the states?

Three wins + three urgent calls to action

Encouraged by drug-makers, lawmakers in several state legislatures have introduced bills to unnecessarily burden and restrict lawful pharmacy compounding, and even lay the groundwork to outlaw it entirely, dressed up as “anti-counterfeit” and “patient safety” measures.

Because many state legislatures are only in session for the first few months of the year, these bills move quickly, and the situation can change daily. We’ll do our best to keep you updated.

Colorado (SB 26-066)

CDI position: OPPOSE

What the bill would do

SB 26-066 claims to target counterfeit drugs or bad actors, but in practice it would make it harder for licensed pharmacies to provide medications, specifically GLP-1s, that many patients rely on, even when a patient's prescriber has determined they need a compounded preparation to meet their individual medical needs.

What you can do

Ask your Colorado patients and providers to take 30 seconds to send a message opposing the bill to their senators on the Health & Human Services committee.

Indiana (SB 282)

CDI position: SUPPORT AS AMENDED

What the bill would do

Thanks to a concerted effort, including more than 1,300 messages sent via our previous advocacy campaign from patients and prescribers to Indiana senators, the version of SB 282 that passed out of the Senate gives the Indiana Board of Pharmacy much-needed oversight over med spas. Language that negatively affected patient access to compounded medications was effectively removed. A huge thank-you to everyone who sent messages to their Indiana senators. Yes, it made a difference!

Although the bill was amended to remove language addressing compounding, it still has to make it through the house — where it can be amended more. APC will be working to ensure the current version of the bill is what is ultimately passed by the Indiana house.

What you can do

Ask your Indiana patients and providers to take 30 seconds to send a message to their representatives asking them to support the bill as amended.

Florida (HB 877 and SB 860)

CDI position: OPPOSE

What the bills would do

Florida lawmakers are considering bills that would restrict pharmacy compounding under the banner of safety. Instead of targeting illegal online sellers or counterfeit products, these bills place new requirements on licensed pharmacies that already operate under federal law and Florida Board of Pharmacy oversight. The practical effect of this bill would be fewer options for patients, delayed treatment, and loss of access — not improved safety.

What you can do

Ask your Florida patients and providers to take 30 seconds to send a message opposing the house bill to their representatives on the Health Professions and Programs subcommittee.

Ding dong, these bills are dead

• Washington state: Thanks to CDI’s advocacy (and the advocacy and organization of the Washington State Pharmacy Association and their compounding SIG), HB 2613 died in committee.
• Virginia: Thanks to CDI’s lobbying and advocacy (and the advocacy of the Virginia Pharmacy Association and others), HB 917 was set aside in committee until next year.(okay, so not dead-dead, but zombified).
• Mississippi: SB 2544 also died in committee on a 9-7 vote.